Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis
No meta-analysis has analysed role of cagrilintide as weight-loss medication in obese individuals. Electronic databases were searched for RCTs involving obese individuals receiving cagrilintide or cagrilintide-2.4 mg with semaglutide-2.4 mg combination (Cagrisema) compared to placebo/active comparat...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Medknow Publications
2024-11-01
|
| Serie: | Indian Journal of Endocrinology and Metabolism |
| Soggetti: | |
| Accesso online: | https://journals.lww.com/10.4103/ijem.ijem_45_24 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|